{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:20:24Z","timestamp":1787721624821,"version":"build-2784847793"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    The atherogenic index of plasma (AIP), calculated as log\n                    <jats:sub>10<\/jats:sub>\n                    (triglycerides\/HDL-C), reflects atherogenic dyslipidemia and is associated with insulin resistance. Its continuous dose-response relationship and incremental predictive value for non-alcoholic fatty liver disease (NAFLD) beyond traditional risk factors remain undefined in community-dwelling older adults\u2014a population with a high metabolic comorbidity burden where low-cost, integrated risk markers are urgently needed.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From 5,783 residents aged \u226565 years without significant alcohol consumption recruited in Zhanjiang, western Guangdong (2023\u20132024), 4,390 were enrolled after exclusions. NAFLD was diagnosed by ultrasonography. AIP was examined using multivariable logistic regression, restricted cubic splines, subgroup analyses, and trend tests with comprehensive confounder adjustment. Incremental predictive value was assessed through a multidimensional evaluation framework comprising ROC curves, calibration, decision curve analysis, net reclassification improvement (NRI), and integrated discrimination improvement (IDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NAFLD prevalence was 42.7%, rising stepwise across AIP quartiles (22.4%, 36.9%, 50.1%, 61.3%; P for trend &amp;lt; 0.001). Each 1-unit increment in AIP was associated with a 6.13-fold higher NAFLD risk (OR 6.13, 95% CI 4.55-8.28) after full adjustment. Restricted cubic splines revealed a strictly linear, threshold-free association (P for nonlinearity = 0.714), consistent across age, residence, hypertension, and diabetes subgroups, with a statistically significant interaction by sex (P for interaction = 0.042). Adding AIP to a baseline clinical model improved discrimination (AUC from 0.786 to 0.811), calibration, clinical net benefit, and risk reclassification (categorical NRI 0.0997, IDI 0.0487; P&amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AIP demonstrates an independent, linear relationship with NAFLD risk in community-dwelling older adults, exhibiting no discernible safe threshold. This low-cost, routine lipid-derived marker supports a \u201csingle-indicator, dual-prevention\u201d strategy for simultaneous NAFLD screening and cardiometabolic risk stratification in primary care, challenging the conventional practice of relying solely on discrete lipid cut-offs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1907673","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:45:00Z","timestamp":1787719500000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Atherogenic index of plasma as a simple marker for NAFLD risk stratification in community-dwelling older adults: a cross-sectional study with incremental predictive value assessment"],"prefix":"10.3389","volume":"17","author":[{"given":"Mengyuan","family":"Xiao","sequence":"first","affiliation":[{"name":"Hypertension Center, Department of Cardiovascular Medicine Center, Affiliated Hospital of Guangdong Medical University","place":["Zhanjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwen","family":"Xiao","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Ji","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Zhuang","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Yuan","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangdong Medical University","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/dom.14484","article-title":"Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications","volume":"24","author":"Byrne","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46946","article-title":"Uncovering the cardiovascular threat: a comprehensive examination of liver fibrosis and subclinical atherosclerosis in non-alcoholic fatty liver disease","volume":"15","author":"Sharma","year":"2023","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30387","article-title":"From NAFLD to NASH: understanding the spectrum of non-alcoholic liver diseases and their consequences","volume":"10","author":"Samy","year":"2024","journal-title":"Heliyon"},{"key":"B5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12933-024-02198-y","article-title":"The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: a systematic review and meta-analysis","volume":"23","author":"Rabiee Rad","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.14218\/jcth.2021.00178","article-title":"Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver","volume":"10","author":"Kaya","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12967-024-04942-0","article-title":"ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK-PPARalpha-CPT1A axis","volume":"22","author":"Dong","year":"2024","journal-title":"J Transl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.954219","article-title":"The atherogenic index of plasma: a novel factor more closely related to non-alcoholic fatty liver disease than other lipid parameters in adults","volume":"9","author":"Liu","year":"2022","journal-title":"Front Nutr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12933-024-02144-y","article-title":"Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism","volume":"23","author":"Min","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12933-024-02314-y","article-title":"Association between atherogenic index of plasma and new-onset stroke in individuals with different glucose metabolism status: insights from CHARLS","volume":"23","author":"Qu","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1460280","article-title":"Association between nontraditional lipid parameters and the risk of type 2 diabetes and prediabetes in patients with nonalcoholic fatty liver disease: from the national health and nutrition examination survey 2017-2020","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.969783","article-title":"Association between the atherogenic index of plasma and new-onset non-alcoholic fatty liver disease in non-obese participants","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40001-022-00731-x","article-title":"Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes","volume":"27","author":"Samimi","year":"2022","journal-title":"Eur J Med Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12933-023-01839-y","article-title":"The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China","volume":"22","author":"Huang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1451383","article-title":"Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study","volume":"15","author":"Shen","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1511952","article-title":"Association between the atherogenic index of plasma and non-alcoholic fatty liver disease in Korean pregnant women: secondary analysis of a prospective cohort study","volume":"12","author":"Shuai","year":"2025","journal-title":"Front Nutr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1405828","article-title":"Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017-2018","volume":"15","author":"Chen","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12876-024-03222-x","article-title":"The association between healthy eating index-2015 with anthropometric, cardiometabolic and hepatic indices among patients with non-alcoholic fatty liver disease","volume":"24","author":"Hosseini","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.14218\/jcth.2024.00311","article-title":"Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (Version 2024)","volume":"12","author":"Fan","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.87216","article-title":"Exploring the relationship between atherogenic index of plasma, body mass index, and fatty liver in obese patients","volume":"17","author":"K","year":"2025","journal-title":"Cureus"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2025.2486565","article-title":"Inflammatory markers mediate association of AIP with kidney failure risk: data from National Health and Nutrition Examination Survey (NHANES) 2005-2018","volume":"47","author":"Guan","year":"2025","journal-title":"Ren Fail"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2016.06.005","article-title":"American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD)","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"key":"B24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.crad.2022.10.003","article-title":"Ultrasound-based hepatic fat quantification: current status and future directions","volume":"78","author":"Seneviratne","year":"2023","journal-title":"Clin Radiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000329","article-title":"Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)","volume":"78","author":"Nabi","year":"2023","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.108235","article-title":"Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease","volume":"180","author":"David","year":"2023","journal-title":"Environ Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v52i4.12441","article-title":"Lipid profile, renal function tests and inflammatory markers in Algerian type 2 diabetic patients","volume":"52","author":"Hadjari","year":"2023","journal-title":"Iran J Public Health"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000037152","article-title":"Association with the plasma atherogenic index with hepatic steatosis and fibrosis in the US population","volume":"103","author":"Li","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12944-023-01966-1","article-title":"Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study","volume":"22","author":"Pan","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3892\/mmr.2025.13693","article-title":"Small dense LDL: an underestimated driver of atherosclerosis (Review)","volume":"32","author":"Bekbossynova","year":"2025","journal-title":"Mol Med Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021162","article-title":"Correlation between the small dense LDL level and nonalcoholic fatty liver disease: possibility of a new biomarker","volume":"99","author":"Hwang","year":"2020","journal-title":"Medicine (Baltimore)."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Delivery Rev"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1907673\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:45:13Z","timestamp":1787719513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1907673\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":32,"alternative-id":["10.3389\/fendo.2026.1907673"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1907673","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1907673"}}